Obesity News and Research

Latest Obesity News and Research

Allergan reports operating results for the third quarter of 2009

Allergan, Inc. today announced operating results for the quarter ended September 30, 2009. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on November 30, 2009 to stockholders of record on November 9, 2009.

29 Oct 2009

Gruve, an activity-based weight management solution from Muve

Muve, Inc., the activity-based weight management company, continues to see increased interest in measurable, sustainable wellness solutions by employers trying to reduce employee health care costs. Muve’s product, the Gruve Solution, helps corporate clients and their employees to become more healthy and productive, while reducing health care costs through measurable results.

29 Oct 2009

Raise awareness about psoriasis: National Psoriasis Foundation's call to psoriasis affected Americans

Today is World Psoriasis Day and the National Psoriasis Foundation is asking all Americans affected by psoriasis and psoriatic arthritis to raise awareness about these diseases by going to www.psoriasis.org/wpd and taking action.

29 Oct 2009

Highlights of new cancer research to be presented at 51st ASTRO Annual Meeting

The following are highlights of new cancer research being presented at the American Society for Radiation Oncology's (ASTRO) 51st Annual Meeting on November 1-5, 2009, in Chicago.

29 Oct 2009

NIEHS supports research to study the potential effects of BPA on human health

Researchers studying the health effects of the chemical bisphenol A (BPA) gathered in North Carolina to launch an integrated research initiative to produce data that will allow for a comprehensive assessment of its possible human health effects.

29 Oct 2009

Proper diet and exercise reduce risk of type 2 diabetes

Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent over 10 years in people at high risk for the disease.

29 Oct 2009

Aerobic exercise not only prevents weight gain, but also inhibits regain of harmful visceral fat

A study conducted by exercise physiologists in the University of Alabama at Birmingham (UAB) Department of Human Studies finds that as little as 80 minutes a week of aerobic or resistance training helps not only to prevent weight gain, but also to inhibit a regain of harmful visceral fat one year after weight loss.

29 Oct 2009

Sixth round of recipients of Pfizer Cardiovascular Research Awards Program announced

Pfizer Canada is pleased to announce the sixth round of recipients of the Pfizer Cardiovascular Research Awards Program. The program, first launched in October 2005, was developed to fund and support cardiovascular research in Canada.

29 Oct 2009

WHO identifies five major causes of premature death

Targeting the five major causes of premature death could increase global life expectancy by almost five years, the WHO said Tuesday, Reuters reports. According to a WHO's Global Health Risks report, which looked at 24 major health risks, "[p]oor childhood nutrition, unsafe sex, alcohol, bad sanitation and hygiene, and high blood pressure are to blame for around a quarter of the 60 million premature deaths around the world each year," the news service writes.

28 Oct 2009

Majority of parents want schools to limit students' access to high-calorie foods

The vast majority of parents want schools to limit students' access to high-calorie chips, sodas and candy and to offer them opportunities for physical activity throughout the day, a new survey by the Alliance for a Healthier Generation shows.

28 Oct 2009

Online weight management support for overweight teen girls and mothers

Professionals from the entertainment industry have teamed with leaders in obesity treatment to create the first web destinations that offer affordable and accessible weight management support to overweight teen girls and their mothers.

28 Oct 2009

Orexigen Therapeutics presents phase 3 trial results of Contrave for treating obesity

Orexigen® Therapeutics, Inc. today announced results from new intent to treat (ITT) analyses from the COR-I and COR-II Phase 3 trials of Contrave® (naltrexone SR/bupropion SR), the first of two late stage Orexigen candidates for the treatment of obesity. These data expand on top-line results announced in July and complement findings from a panel discussion on Saturday where the Company presented data on Contrave patients who completed 56 weeks of therapy.

28 Oct 2009

EnteroMedics to reduce its workforce and operating costs

EnteroMedics Inc., today announced that it has implemented a plan to reduce its workforce and operating costs in order to preserve capital and streamline its operations following the announcement of top-line results from its pivotal EMPOWER study on October 2, 2009. The reduction in force will lower the number of employees by 40%, to a total of 33, by November 15, 2009.

28 Oct 2009

Arena Pharmaceuticals presents data from its Phase 3 trial of LOrcaserin

Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.

28 Oct 2009

National Institutes of Health awards $735,000 grant for prenatal obesity and diabetes research

The National Institutes of Health has awarded Clemson University professor Maria Mayorga and Medical University of South Carolina professor Kelly Hunt a $735,000 grant to study the effects of a mother's obesity and diabetes on infant health in certain ethnic groups.

28 Oct 2009

Commit 2B Fit receives "Exemplary Practices in Childhood Obesity in Florida Award"

Commit 2B Fit®, a school-based program to promote overall childhood wellness, received Honorable Mention in statewide Exemplary Practices in Childhood Obesity in Florida Award, presented by the Florida Initiative for Children’s HealthCare Quality (FLICHQ). FLICHQ, evaluated programs around the state according to its “five I’s: Impact, Inclusion, Improvability, Implementation and Innovation.”

28 Oct 2009

Pediatric and adolescent patients who receive antipsychotic medications experience weight gain

Many pediatric and adolescent patients who received second-generation antipsychotic medications experienced significant weight gain, along with varied adverse effects on cholesterol and triglyceride levels and other metabolic measures, according to a study in the October 28 issue of JAMA.

28 Oct 2009

Renowned surgeons to discuss latest advances in laparoscopic surgery at upcoming MISS meeting

The upcoming prestigious Minimally Invasive Surgery Symposium (MISS) will include discussion of advances in metabolic surgery, a robotic approach to colon surgery, single-port bariatric surgery, transoral gastroplasty, and other "frontier" topics.

28 Oct 2009

Mirafit fbcx reduces human body absorption of consumed fat

A scientific study to be presented today at the annual meeting of The Obesity Society will confirm significant weight loss using the pill mirafit fbcx®. Dr. K-L Catherine Jen and Dr. Joseph Artiss, principals at ArtJen Complexus USA, LLC, will present these clinical study findings today, October 27, at The Obesity Society 2009 annual scientific meeting at the Marriott Wardman Park Hotel in Washington, D.C., The Obesity Society's 27th annual scientific meeting.

28 Oct 2009

GI Dynamics’ EndoBarrier Gastrointestinal Liner for pre-surgical weight loss treatment demonstrates safety

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced data which support the safety and efficacy of the EndoBarrier™ Gastrointestinal Liner for pre-surgical weight loss treatment, along with a positive effect on glucose homeostasis in morbidly obese patients with type 2 diabetes mellitus.

27 Oct 2009

Obesity News and Research

Latest Obesity News and Research

Allergan reports operating results for the third quarter of 2009

Gruve, an activity-based weight management solution from Muve

Raise awareness about psoriasis: National Psoriasis Foundation's call to psoriasis affected Americans

Highlights of new cancer research to be presented at 51st ASTRO Annual Meeting

NIEHS supports research to study the potential effects of BPA on human health

Proper diet and exercise reduce risk of type 2 diabetes

Aerobic exercise not only prevents weight gain, but also inhibits regain of harmful visceral fat

Sixth round of recipients of Pfizer Cardiovascular Research Awards Program announced

WHO identifies five major causes of premature death

Majority of parents want schools to limit students' access to high-calorie foods

Online weight management support for overweight teen girls and mothers

Orexigen Therapeutics presents phase 3 trial results of Contrave for treating obesity

EnteroMedics to reduce its workforce and operating costs

Arena Pharmaceuticals presents data from its Phase 3 trial of LOrcaserin

National Institutes of Health awards $735,000 grant for prenatal obesity and diabetes research

Commit 2B Fit receives "Exemplary Practices in Childhood Obesity in Florida Award"

Pediatric and adolescent patients who receive antipsychotic medications experience weight gain

Renowned surgeons to discuss latest advances in laparoscopic surgery at upcoming MISS meeting

Mirafit fbcx reduces human body absorption of consumed fat

GI Dynamics’ EndoBarrier Gastrointestinal Liner for pre-surgical weight loss treatment demonstrates safety

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Obesity News and Research

Latest Obesity News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in